StockTipsArenaBeta

BUY Divi's Laboratories Limited — Kavita Jain, Arihant Capital Markets

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byKavita Jain, Arihant Capital MarketsHorizon: NA (inferred Swing (≤2wk))14 Jul 2026via CNBC Awaaz.

Entry₹7,130Inferred
Target₹7,350
Total upside +3.09% (call closed)
Stop loss₹6,950-2.52% risk
Exit₹7,35016 Jul 2026, 10:35 am
Target hit+3.09%0.00%upside left
Follow Kavita Jain for new calls(44% target hit, 70 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 1 active Swing call on DIVISLABSee 105 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 3:07 am IST
4 supporting2 neutral0 opposing
Supports the BUY call (4)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·16 Jul · today

1500% Dividend Bonanza! Pharma Stock In Spotlight After Mega Payout; Record Date Announced

NewsGoogle News·14 Jul · yesterday

(opens in new tab)

Divi's Laboratories Recommends ₹30 Final Dividend for FY26

NewsGoogle News·13 Jul · 2d ago

(opens in new tab)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·14 Jul · 2d ago

Neutral / worth noting (2)

Divis Laboratories reduces carbon footprint in FY 2025-26

NewsGoogle News·15 Jul · today

(opens in new tab)

Divis Laboratories fixes July 24 record date for ₹30 dividend

NewsGoogle News·15 Jul · today

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Kavita Jain, Arihant Capital Markets

Every call and its outcome